Do alcohol, colchicine, histamine, metformin, and proton‑pump inhibitors cause or exacerbate megaloblastic anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Megaloblastic Anemia and Medication-Induced Vitamin B12 Deficiency

Yes, alcohol, colchicine, metformin, and PPIs can cause or worsen megaloblastic anemia through vitamin B12 deficiency, while histamine H2 receptor antagonists also pose this risk—histamine itself does not cause megaloblastic anemia.

Medications That Cause Megaloblastic Anemia

Metformin

Metformin is the most extensively documented medication causing vitamin B12 deficiency and subsequent megaloblastic anemia. The 2024 NICE guideline explicitly lists metformin as a risk factor for vitamin B12 deficiency 1. The mechanism involves blocking calcium-dependent absorption of the intrinsic factor-B12 complex in the terminal ileum 2.

Key evidence:

  • Metformin users have 2.92 times higher odds of B12 deficiency (≤148 pmol/L) compared to non-users, even after adjusting for confounders 2
  • Dose and duration are independent risk factors—risk increases substantially after 5 years of use when hepatic B12 stores become depleted 3
  • Meta-analysis of 6 RCTs showed dose-dependent reductions in serum B12 levels (-53.93 pmol/L) 2

Monitor vitamin B12 levels periodically in all metformin users, especially after 4-5 years of therapy 1, 2.

Proton Pump Inhibitors (PPIs)

PPIs are recognized as causing vitamin B12 deficiency in the 2024 NICE guideline 1 and multiple research studies 4, 5. The mechanism involves reduced gastric acid impairing B12 release from food proteins. Risk increases with use exceeding 12 months 4.

Recent case reports demonstrate severe combined B12 and folate deficiency in long-term PPI users presenting with features mimicking hemolytic anemia (elevated LDH, undetectable haptoglobin) but with low reticulocyte counts—a hallmark of ineffective erythropoiesis in megaloblastic anemia 6.

Histamine H2 Receptor Antagonists

The 2024 NICE guideline lists H2 receptor antagonists as medications causing vitamin B12 deficiency 1. Like PPIs, they reduce gastric acid production, impairing B12 absorption. Risk increases with use exceeding 12 months 4.

Important distinction: Histamine H2 receptor antagonists (medications) cause B12 deficiency; histamine (the endogenous compound) does not cause megaloblastic anemia.

Colchicine

Colchicine is explicitly listed in the 2024 NICE guideline as causing vitamin B12 deficiency 1. The FDA drug label warns of blood dyscrasias including aplastic anemia, thrombocytopenia, and pancytopenia with therapeutic doses 7. The mechanism involves disruption of intestinal absorption through microtubule inhibition affecting enterocyte function 7.

Alcohol

Alcohol causes megaloblastic anemia primarily through folate deficiency, not B12 deficiency. Alcohol produces both dietary folate deficiency and a direct antifolate effect 8. Megaloblastic anemia from folate deficiency is the most common cause of low hematocrit in hospitalized alcoholics 8.

Alcohol also causes sideroblastic anemia (a separate mechanism) through inhibition of heme synthesis, which can coexist with folate-deficient megaloblastic anemia 8.

Clinical Approach

Risk Factor Assessment

Monitor B12 levels in patients with:

  • Metformin use >4 months 1
  • PPI or H2 blocker use >12 months 1, 4
  • Any duration of colchicine use 1
  • Chronic alcohol use (check folate primarily) 8

Accelerating Factors

B12 deficiency develops faster when multiple risk factors combine:

  • Concurrent PPI/H2 blocker + metformin use 3
  • Elderly patients (>75 years) 1
  • Bariatric surgery 4
  • Increased RBC turnover 3

Diagnostic Pitfalls

Do not rely solely on serum B12 levels. When B12 is in the indeterminate range (borderline low), measure methylmalonic acid (MMA) and homocysteine to confirm functional deficiency 1, 3.

Beware of pseudohemolysis: Combined B12/folate deficiency can present with elevated LDH and low haptoglobin mimicking hemolytic anemia, but the low reticulocyte count reveals ineffective erythropoiesis instead 6.

Management

  • Discontinue or reduce the offending medication when possible 6
  • Oral high-dose B12 (1-2 mg daily) is as effective as intramuscular therapy for most patients 4, 5
  • Use intramuscular B12 for severe deficiency or neurologic symptoms 4
  • For ongoing metformin use: prophylactic calcium and B12 supplements, with regular monitoring 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.